Daiwa Securities Group
INO icon

Daiwa Securities Group’s Inovio Pharmaceuticals INO Stock Holding History

Daiwa Securities Group’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60
Closed – – 1355
2023
Q3 		$0 Hold
60
– – ﹤0.01% 1311
2023
Q2 		$0 Sell
60
-3,263
-98% -$26.3K ﹤0.01% 1335
2023
Q1 		$33K Buy
3,323
+641
+24% +$10.9K ﹤0.01% 1060
2022
Q4 		$50K Sell
2,682
-674
-20% -$15.3K ﹤0.01% 1037
2022
Q3 		$69K Sell
3,356
-946
-22% -$24.2K ﹤0.01% 1033
2022
Q2 		$89K Buy
4,302
+2,557
+147% +$72.1K ﹤0.01% 1034
2022
Q1 		$75K Buy
1,745
+529
+44% +$23.8K ﹤0.01% 1068
2021
Q4 		$73K Buy
1,216
+584
+92% +$46.8K ﹤0.01% 1063
2021
Q3 		$54K Buy
632
+598
+1,759% +$60K ﹤0.01% 1047
2021
Q2 		$4K Hold
34
– – ﹤0.01% 1089
2021
Q1 		$4K Buy
34
+7
+26% +$921 ﹤0.01% 1090
2020
Q4 		$3K Sell
27
-48
-64% -$6.39K ﹤0.01% 1085
2020
Q3 		$10K Buy
75
+28
+60% +$5.84K ﹤0.01% 1038
2020
Q2 		$4K Hold
47
– – ﹤0.01% 1122
2020
Q1 		$4K Buy
47
+5
+12% +$308 ﹤0.01% 1117
2019
Q4 		$2K Hold
42
– – ﹤0.01% 1161
2019
Q3 		$1K Hold
42
– – ﹤0.01% 1152
2019
Q2 		$1K Hold
42
– – ﹤0.01% 1177
2019
Q1 		$2K Hold
42
– – ﹤0.01% 1131
2018
Q4 		$2K Hold
42
– – ﹤0.01% 1106
2018
Q3 		$3K Hold
42
– – ﹤0.01% 1106
2018
Q2 		$2K Hold
42
– – ﹤0.01% 1138
2018
Q1 		$2K Buy
+42
New +$2.27K ﹤0.01% 1127

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Daiwa Securities Group's INO Position: Q4 2023 in Review

Daiwa Securities Group sold out of Inovio Pharmaceuticals (INO) in Q4 2023, closing a stake of 60 shares.

Daiwa Securities Group first reported a position in INO in Q1 2018 and held it in 23 quarters. The position peaked at $89K in Q2 2022. 113 funds tracked by Wall St. Rank hold INO as of Q4 2023.

  • Daiwa Securities Group reported no remaining Inovio Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 60 Inovio Pharmaceuticals shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Inovio Pharmaceuticals in Q1 2018 and held it in 23 quarters.
  • Daiwa Securities Group's Inovio Pharmaceuticals position peaked at $89K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.